Healthcare Professional Financial Transparency Reporting
Biogen is committed to meeting all global transparency requirements, including the Physician Payments Sunshine Act in the United States and the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code in the European Union. As is our obligation, we record all transfers of value to healthcare professionals and organisations and report pursuant to the applicable local codes and laws. We take care to ensure that the data that we submit is as detailed, comprehensive and clear as possible. This information is an important part of our ongoing collaboration with the healthcare community. Ultimately, the data we submit today can benefit patients in the future.
In Australia: As a member of Medicines Australia, Biogen Australia Pty Ltd endorses the Medicines Australia Code of Conduct and has undertaken to be open and transparent when we provide a reportable payment or transfer of value to a healthcare professional.
Reportable payments or transfers of value are:
- Payments for the provision of services, such as: giving a lecture, chairing an educational meeting, providing advice as a member of an Advisory Board or as a Consultant
- Airfares, accommodation and/or conference registration fees to attend medical education as part of those services
Biogen Australia has prepared reports for publication in accordance with the Medicines Australia Code of Conduct, Edition 18 and Australia’s Privacy legislation.
For transfers of value made between 1 October 2015 and 30 September 2016, the reports identify healthcare professionals by name where their consent has been provided, and otherwise report the information, in aggregate. All transfers of value made from 1 October 2016 are reported on a mandatory basis and healthcare professionals should reasonably expect that such transfers of value will be disclosed, by name.
The reports below are designed to be read on this website and are also provided as a downloadable PDF and CSV files. Reports will be available for at least three years from the date of publication. Please note that for all Biogen Australia transparency reports published after 30 August 2019, this information is held in a database administered by Medicines Australia. This database is designed to be searchable as well as downloadable as a CSV file. For further information about the details in reports published from September 2019 onwards, or to search the Medicines Australia database, please visit www.DisclosureAustralia.com.au.
To comply with our privacy obligations, the reports may be amended from time to time. Any use or disclosure of the data by a third-party is the responsibility of that third-party who must comply with the Australian Privacy Act 1988.
For further information about the details in the report, please go to https://medicinesaustralia.com.au/.